Adherence to antiretroviral therapy: How much is enough?

被引:35
作者
Gulick, Roy M. [1 ]
机构
[1] Cornell Univ, Weill Med Coll, Div Int Med & Infect Dis, Cornell HIV Clin Trials Unit, New York, NY 10021 USA
关键词
D O I
10.1086/507549
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:942 / 944
页数:3
相关论文
共 21 条
[1]   Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression [J].
Bangsberg, David R. .
CLINICAL INFECTIOUS DISEASES, 2006, 43 (07) :939-941
[2]   Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG Adherence Instruments [J].
Chesney, MA ;
Ickovics, JR ;
Chambers, DB ;
Gifford, AL ;
Neidig, J ;
Zwickl, B ;
Wu, AW .
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2000, 12 (03) :255-266
[3]   A proof-of-concept study of short-cycle intermittent antiretroviral therapy with a once-daily regimen of didanosine, lamivudine, and efavirenz for the treatment of chronic HIV infection [J].
Dybul, M ;
Nies-Kraske, E ;
Dewar, R ;
Maldarelli, F ;
Hallahan, CW ;
Daucher, M ;
Piscitelli, SC ;
Ehler, L ;
Weigand, A ;
Palmer, S ;
Metcalf, JA ;
Davey, RT ;
Kress, DMR ;
Powers, A ;
Beck, I ;
Frenkel, L ;
Baseler, M ;
Coffin, J ;
Fauci, AS .
JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (11) :1974-1982
[4]   Four measures of antiretroviral medication adherence and virologic response in AIDS clinical trials group study 359 [J].
Fletcher, CV ;
Testa, MA ;
Brundage, RC ;
Chesney, MA ;
Haubrich, R ;
Acosta, EP ;
Martinez, A ;
Jiang, HY ;
Gulick, RM .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 40 (03) :301-306
[5]   Efficacy and safety of tenofovir DF vs stavuldine in combination therapy in antiretroviral-naive patients - A 3-year randomized trial [J].
Gallant, JE ;
Staszewski, S ;
Pozniak, AL ;
DeJesus, E ;
Suleiman, JMAH ;
Miller, MD ;
Coakley, DF ;
Lu, B ;
Toole, JJ ;
Cheng, AK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (02) :191-201
[6]   Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy [J].
Gulick, RM ;
Mellors, JW ;
Havlir, D ;
Eron, JJ ;
Gonzalez, C ;
McMahon, D ;
Richman, DD ;
Valentine, FT ;
Jonas, L ;
Meibohm, A ;
Emini, EA ;
Chodakewitz, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) :734-739
[7]   Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection [J].
Gulick, RM ;
Ribaudo, HJ ;
Shikuma, CM ;
Lustgarten, S ;
Squires, KE ;
Meyer, WA ;
Acosta, EP ;
Schackman, BR ;
Pilcher, CD ;
Murphy, RL ;
Maher, WE ;
Witt, MD ;
Reichman, RC ;
Snyder, S ;
Klingman, KL ;
Kuritzkes, DR .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (18) :1850-1861
[8]  
Haas DW, 2004, AIDS, V18, P2391
[9]   Treatment for adult HIV infection - 2006 recommendations of the International AIDS Society-USA panel [J].
Hammer, Scott M. ;
Saag, Michael S. ;
Schechter, Mauro ;
Montaner, Julio S. G. ;
Schooley, Robert T. ;
Jacobsen, Donna M. ;
Thompson, Melanie A. ;
Carpenter, Charles C. J. ;
Fischl, Margaret A. ;
Gazzard, Brian G. ;
Gatell, Jose M. ;
Hirsch, Martin S. ;
Katzenstein, David A. ;
Richman, Douglas D. ;
Vella, Stefano ;
Yeni, Patrick G. ;
Volberding, Paul A. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (07) :827-843
[10]   A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less [J].
Hammer, SM ;
Squires, KE ;
Hughes, MD ;
Grimes, JM ;
Demeter, LM ;
Currier, JS ;
Eron, JJ ;
Feinberg, JE ;
Balfour, HH ;
Dayton, LR ;
Chodakewitz, JA ;
Fischl, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) :725-733